Cutler Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 972 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1365 |
|
|
2023
Q3 | – | Sell |
-800
| Closed | -$69K | – | 1451 |
|
|
2023
Q2 | $69K | Hold |
800
| – | – | 0.01% | 548 |
|
|
2023
Q1 | $77K | Sell |
800
-1,349
| -63% | -$130K | 0.01% | 539 |
|
|
2022
Q4 | $222K | Buy |
+2,149
| New | +$222K | 0.02% | 421 |
|
|
2022
Q3 | – | Sell |
-2,087
| Closed | -$172K | – | 1942 |
|
|
2022
Q2 | $172K | Buy |
+2,087
| New | +$172K | 0.01% | 511 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2007 |
|
|
2021
Q4 | – | Sell |
-2,170
| Closed | -$167K | – | 2089 |
|
|
2021
Q3 | $167K | Sell |
2,170
-300
| -12% | -$23.1K | 0.01% | 759 |
|
|
2021
Q2 | $206K | Buy |
2,470
+2,370
| +2,370% | +$198K | 0.01% | 727 |
|
|
2021
Q1 | $7K | Sell |
100
-5,426
| -98% | -$380K | ﹤0.01% | 1705 |
|
|
2020
Q4 | $484K | Buy |
5,526
+4,326
| +361% | +$379K | 0.02% | 357 |
|
|
2020
Q3 | $91K | Buy |
+1,200
| New | +$91K | 0.01% | 698 |
|
|
2020
Q2 | – | Sell |
-2,000
| Closed | -$169K | – | 1582 |
|
|
2020
Q1 | $169K | Buy |
2,000
+100
| +5% | +$8.45K | 0.01% | 476 |
|
|
2019
Q4 | $160K | Buy |
1,900
+1,800
| +1,800% | +$152K | 0.01% | 566 |
|
|
2019
Q3 | $6K | Sell |
100
-6,800
| -99% | -$408K | ﹤0.01% | 1255 |
|
|
2019
Q2 | $590K | Buy |
6,900
+4,550
| +194% | +$389K | 0.05% | 225 |
|
|
2019
Q1 | $208K | Sell |
2,350
-18,184
| -89% | -$1.61M | 0.02% | 434 |
|
|
2018
Q4 | $1.75M | Buy |
20,534
+9,348
| +84% | +$796K | 0.17% | 71 |
|
|
2018
Q3 | $1.08M | Buy |
11,186
+3,628
| +48% | +$352K | 0.08% | 187 |
|
|
2018
Q2 | $711K | Buy |
7,558
+972
| +15% | +$91.4K | 0.06% | 265 |
|
|
2018
Q1 | $533K | Sell |
6,586
-5,987
| -48% | -$485K | 0.05% | 284 |
|
|
2017
Q4 | $1.12M | Sell |
12,573
-545
| -4% | -$48.6K | 0.05% | 226 |
|
|
2017
Q3 | $1.22M | Buy |
13,118
+6,923
| +112% | +$644K | 0.05% | 214 |
|
|
2017
Q2 | $562K | Sell |
6,195
-16,102
| -72% | -$1.46M | 0.02% | 450 |
|
|
2017
Q1 | $1.96M | Buy |
22,297
+11,850
| +113% | +$1.04M | 0.08% | 173 |
|
|
2016
Q4 | $865K | Sell |
10,447
-19,409
| -65% | -$1.61M | 0.03% | 326 |
|
|
2016
Q3 | $2.76M | Buy |
29,856
+15,440
| +107% | +$1.43M | 0.12% | 86 |
|
|
2016
Q2 | $1.12M | Sell |
14,416
-3,333
| -19% | -$259K | 0.06% | 174 |
|
|
2016
Q1 | $1.46M | Buy |
17,749
+14,894
| +522% | +$1.23M | 0.1% | 119 |
|
|
2015
Q4 | $299K | Buy |
+2,855
| New | +$299K | 0.02% | 534 |
|